Protein and peptide biopharmaceuticals: An overview
Access Status
Fulltext not available
Authors
Agyei, D.
Ahmed, I.
Akram, Z.
Iqbal, H.
Danquah, Michael
Date
2017Type
Journal Article
Metadata
Show full item recordCitation
Agyei, D. and Ahmed, I. and Akram, Z. and Iqbal, H. and Danquah, M. 2017. Protein and peptide biopharmaceuticals: An overview. Protein and Peptide Letters. 24 (2): pp. 94-101.
Source Title
Protein and Peptide Letters
ISSN
School
Curtin Malaysia
Collection
Abstract
© 2017 Bentham Science Publishers. Bioactive proteins and peptides are recognised as novel therapeutic molecules with varying biological properties for potential medical applications. Development of protein and peptidebased therapeutic products for human use is growing steadily as they continue to receive an increasing rate of approval by the United States Food and Drugs Administration (US FDA). In this short review, we describe the current status and methodologies involved in the synthesis of protein and peptide biopharmaceuticals with an emphasis on the drivers and restrains to their exploitation in the therapeutic products sector.
Related items
Showing items related by title, author, creator and subject.
-
Meng, Xingqiong (Rosie) (2010)Background. Aging is associated with progressive loss of muscle (sarcopenia), which can lead to reduced muscle strength and an increased risk of falls. Sarcopenia exists in otherwise healthy elderly people and its aetiology ...
-
Tidy, R.; Lam, V.; Fimognari, N.; Mamo, John; Hackett, M. (2016)© 2016 Elsevier B.V.Fourier transform infrared (FTIR) spectroscopy has been well documented to discriminate between protein secondary structures, at the micron scale. This capability has enabled in situ localization of ...
-
Dillon, Tharam S.; Sidhu, Amandeep; Chang, Elizabeth (2005)In this paper, we proposed a Protein Ontology to integrate protein data and information from various Protein Data Sources. Protein Ontology provides the technical and scientific infrastructure and knowledge to allow ...